SBH
DGX icon

Segall Bryant & Hamill’s Quest Diagnostics DGX Stock Holding History

Segall Bryant & Hamill’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,588
Closed -$523K – 721
2020
Q2 		$523K Sell
4,588
-10,088
-69% -$1.07M 0.01% 577
2020
Q1 		$1.18M Sell
14,676
-3,280
-18% -$340K 0.02% 419
2019
Q4 		$1.92M Hold
17,956
– – 0.03% 399
2019
Q3 		$1.92M Sell
17,956
-600
-3% -$61.6K 0.03% 412
2019
Q2 		$1.89M Sell
18,556
-219
-1% -$21K 0.03% 416
2019
Q1 		$1.69M Buy
18,775
+661
+4% +$57.3K 0.03% 438
2018
Q4 		$1.51M Buy
18,114
+4,050
+29% +$380K 0.03% 448
2018
Q3 		$1.52M Sell
14,064
-890
-6% -$97.6K 0.02% 482
2018
Q2 		$1.64M Buy
+14,954
New +$1.56M 0.03% 460

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Segall Bryant & Hamill's DGX Position: Q3 2020 in Review

Segall Bryant & Hamill sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 4,588 shares — an estimated $523K sold.

Segall Bryant & Hamill first reported a position in DGX in Q2 2018 and held it in 9 quarters. The position peaked at $1.92M in Q3 2019. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Segall Bryant & Hamill reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 4,588 Quest Diagnostics shares in Q3 2020, an estimated $523K.
  • Segall Bryant & Hamill first reported a position in Quest Diagnostics in Q2 2018 and held it in 9 quarters.
  • Segall Bryant & Hamill's Quest Diagnostics position peaked at $1.92M in Q3 2019.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Segall Bryant & Hamill's 13F filing for Q3 2020, filed 13 Nov 2020.